Compare EVGO & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVGO | RXST |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | 331 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.9M | 305.0M |
| IPO Year | N/A | 2021 |
| Metric | EVGO | RXST |
|---|---|---|
| Price | $2.13 | $7.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 10 |
| Target Price | $5.23 | ★ $9.78 |
| AVG Volume (30 Days) | ★ 4.6M | 730.0K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | $16.45 | N/A |
| Revenue Next Year | $29.44 | $9.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.64 | $5.90 |
| 52 Week High | $5.18 | $16.73 |
| Indicator | EVGO | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 54.82 |
| Support Level | $1.64 | $7.34 |
| Resistance Level | $3.27 | $9.11 |
| Average True Range (ATR) | 0.11 | 0.41 |
| MACD | 0.07 | 0.15 |
| Stochastic Oscillator | 96.08 | 92.50 |
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.